Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,468.00    38.00 (0.86%)
Bid:
4,454.00
Ask:
4,460.00
Spread: 6.00 (0.135%)
Market Cap: £2.08b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
 



17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010. 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating. 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (£100m) and Hull BSF (£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts. 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from £3.6bn to £3.2bn since 30 June 2009. However, this forward order book is supplemented by over £900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year. 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

Morgan Sindall plc

Tel: 020 7307 9200

Paul Smith, Chief Executive

David Mulligan, Finance Director

Blythe Weigh Communications

Tel: 020 7138 3204 

Tim Blythe

Mob: 07816 924626

Paul Weigh

Mob: 07989 129658 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKAKBOBDDNBD
Date   Source Headline
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.